FTC and Four States Sue WPATH Over Gender-Affirming Care Guidelines
The Federal Trade Commission (FTC) along with four red states have filed a lawsuit against the World Professional Association for Transgender Health (WPATH). This nonprofit medical professional organization specializes in the research and treatment of gender dysphoria and has been targeted due to its practice guidelines supporting gender-affirming care services for minors.
Legal Action in Texas Federal Court
The lawsuit was officially filed on Wednesday in a Texas federal court, a jurisdiction known for its receptiveness to conservative legal approaches to limit gender-affirming services. The plaintiffs claim that WPATH misrepresented medical evidence in their guidelines. Allegations include exaggerating the role of gender-affirming care in reducing suicide rates and downplaying potential lifelong medical side effects, which they claim misled consumers into purchasing these services.
FTC’s Standpoint on Medical Claims
FTC Chairman Andrew Ferguson emphasized the necessity of truthful and evidence-based claims in medical treatments. He stated in a news release, “Children, but especially their parents, need to have complete and truthful information when making decisions about purchasing medical services. For decades, the FTC has taken action against companies that make misleading and unfounded health claims.”
The lawsuit seeks a permanent injunction and financial compensation. In response, WPATH asserted that the FTC should not interfere in individual medical decision-making processes and argued that the FTC lacks jurisdiction over its non-commercial statements.
Public Comments and Medical Evidence
The lawsuit includes public comments collected by the FTC after a workshop on “misleading marketing” in gender-affirming care for minors. These comments often describe negative physical effects from previous transitional care. The complaint accuses WPATH of deceiving consumers and contributing to the rise in pediatric medical transitions, which are now covered by most major insurance companies based on WPATH’s standards of care.
The plaintiffs reference a U.S. Department of Health and Human Services report from November which found the evidence for gender-affirming services for minors to be weak or inconclusive, recommending psychological interventions instead. Additionally, international reviews such as the British Cass Review are cited.
Current Landscape and Historical Context
Despite the legal challenges, gender-affirming care services for minors are supported by major medical associations like the American Medical Association and the American Academy of Pediatrics. However, 26 states have enacted laws restricting these services. The lawsuit is part of a broader initiative by the Trump administration and conservative entities to limit gender-affirming care, which has involved subpoenas, criminal investigations, and regulatory threats.
While some legal actions have been blocked or rejected, there have been victories for opponents of gender-affirming care. Several pediatric providers have ceased offering these services, and settlements have been reached with institutions like Texas Children’s Hospital and the Cleveland Clinic to focus resources on detransitioning services.
Support for the Lawsuit
The lawsuit is endorsed by the administration’s health leadership. HHS Secretary Robert F. Kennedy Jr. praised the FTC’s actions, stating, “Medical organizations must be guided by science, disclose conflicts and put patients first. Children deserve the highest standard of care, parents deserve honest information and the American people deserve accountability.”
For more detailed information about this ongoing legal matter, visit the source here.
“`
